Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
NCT05149014
·
clinicaltrials.gov ↗
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
HER2-positive Breast Cancer
Sponsor
Daiichi Sankyo France